Literature DB >> 7911456

Immunohistochemical evaluation of P-glycoprotein in human malignancies by monoclonal antibody MC57.

E Leonardo1, G Valente, S Cappia, M Cianfriglia, G Arancia, S Meschini, G V Scagliotti.   

Abstract

P-glycoprotein expression was analyzed on 137 formalin-fixed, paraffin-embedded human tumours by monoclonal antibody (MAb) MC57. This MAb recognizes an extracellular human specific P-glycoprotein epitope and defines their multidrug resistance (MDR) phenotype by its binding on cells. Immunohistochemistry indicated that this MAb reacted in human cells and tissues in the same pattern as that found with other MAbs to P-glycoprotein. However, the present extensive study demonstrated that MAb MC57 is a highly specific reagent for the evaluation of an extracellular P-glycoprotein epitope preserved after fixation procedures and that this MAb is available to assess P-glycoprotein expression in routinely processed human tumour specimens.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7911456     DOI: 10.1002/ijc.2910570613

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  4 in total

1.  P-glycoprotein expression in soft-tissue sarcomas.

Authors:  H Nakanishi; A Myoui; T Ochi; K Aozasa
Journal:  J Cancer Res Clin Oncol       Date:  1997       Impact factor: 4.553

2.  Expression of MK-1 and RegIV and its clinicopathological significances in the benign and malignant lesions of gallbladder.

Authors:  Leping Yang; Sigen Lan; Jieqiong Liu; Zhulin Yang
Journal:  Diagn Pathol       Date:  2011-10-21       Impact factor: 2.644

3.  Expression of DNA-repair proteins and their significance in pancreatic cancer and non-cancerous pancreatic tissues of Sprague-Dawley rats.

Authors:  Xing-guo Tan; Zhu-lin Yang; Le-ping Yang; Xiong-ying Miao
Journal:  World J Surg Oncol       Date:  2014-02-06       Impact factor: 2.754

4.  PSCA and Oct-4 expression in the benign and malignant lesions of gallbladder: implication for carcinogenesis, progression, and prognosis of gallbladder adenocarcinoma.

Authors:  Qiong Zou; Leping Yang; Zhulin Yang; Jiangsheng Huang; Xi Fu
Journal:  Biomed Res Int       Date:  2013-08-01       Impact factor: 3.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.